Company Intelligence Profile

Bioplus Life Sciences Private Limited

Bioplus Life Sciences is a Bangalore-based contract research, development and manufacturing company for pharma, making APIs and oral tablets and capsules.

CIN: U24232KA2004PTC033578ActiveRoC Bangalore

Last updated 20 October 2026

AI OverviewGenerated from public records

Bioplus Life Sciences Private Limited is a Bangalore-based contract research, development and manufacturing company for the pharma industry. It makes APIs and intermediates and also produces oral tablets and capsules. The company was incorporated on 19 March 2004 and is an active unlisted private company. It reported revenue of ₹90.96 Cr in FY2022 and has an open charge of ₹85.40 Cr registered in April 2025.

AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.

See what AICA knows about Bioplus Life Sciences

Deeper analysis, financial signals and peer comparisons.

Book a demo

Company Identity

Registered nameBioplus Life Sciences Private Limited
CINU24232KA2004PTC033578
StatusActive
ListingUnlisted
Incorporated19 March 2004
ROCRoC Bangalore
Sector (NIC)Pharma & Life Sciences
Registered addressS.No.10 – 1A, Hoodi Village, Krishnarajapuram Hobli, Bangalore, Karnataka, India – 560048
Authorized capitalRs 36.35 Cr
Paid-up capitalRs 3 Cr

Source: www.thecompanycheck.com

Business Overview

  • Bioplus Life Sciences is a cGMP biopharmaceutical contract research, development and manufacturing company based in Bangalore.
  • It works with global pharma and biotech companies on API and intermediate manufacturing.
  • It also develops and manufactures oral solid dose formulations such as tablets and capsules.
  • The company was incorporated on 19 March 2004 and was earlier known as Bioplus Pharmaceutical Pvt Ltd.

Source: www.thecompanycheck.com

Directors

NameDINRoleAppointed
Sunjeev Aurora02244616Director-
Sundeep Aurora02244640Director-
Rhea Ishani Aurora11351935Additional Director29 Oct 2025
Neha Aurora07283383Additional Director29 Oct 2025

Source: www.thecompanycheck.com

Financials

FY2022
  • Revenue ₹90.96 Cr

Source: www.thecompanycheck.com

Charges & Borrowings

Open charge₹85.40 Cr, registered 15 Apr 2025
Satisfied charge₹20.6 Cr with Canara Bank, registered 09 Nov 2005, satisfied 12 Jun 2025

Source: www.thecompanycheck.com

Competitors

WuXi AppTec
CRO and CDMO company based in China
Eurofins Scientific
testing and CRO company based in Luxembourg
Ipsen
biopharma company
CHEPLAPHARM
branded pharma company based in Germany
ANI Pharmaceuticals
branded and generic pharma company based in the US

Source: www.thecompanycheck.com

Frequently Asked Questions

What does Bioplus Life Sciences Private Limited do?
It is a Bangalore-based contract research, development and manufacturing company for pharma. It makes APIs and intermediates and develops and manufactures oral solid dose products such as tablets and capsules.
Who are the directors of Bioplus Life Sciences Private Limited?
The directors are Sunjeev Aurora and Sundeep Aurora. Rhea Ishani Aurora and Neha Aurora were appointed Additional Directors on 29 Oct 2025.
When was Bioplus Life Sciences Private Limited incorporated?
It was incorporated on 19 March 2004 and is registered with the RoC Bangalore. It is an active unlisted private limited company.
What is the CIN of Bioplus Life Sciences Private Limited?
The CIN of Bioplus Life Sciences Private Limited is U24232KA2004PTC033578.
Where is Bioplus Life Sciences Private Limited registered?
The registered office is at S.No.10 - 1A, Hoodi Village, Krishnarajapuram Hobli, Bangalore, Karnataka, 560048.

Recur Market

Which lenders fit a company like Bioplus Life Sciences Private Limited?

Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.

Similar Pharma & Life Sciences companies

More on Recur Club

Explore on Recur Club

More from Recur Club

Looking for business funding?

Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.

Disclaimer: Company information shown on this page is compiled from public records and third-party sources. It may be incomplete, outdated, or contain inaccuracies, and is provided for general informational purposes only. Please verify details independently before relying on them.